Partners Group to acquire majority stake in European CDMO Pharmathen
Swiss private equity firm Partners Group has agreed on behalf of its clients to acquire a majority stake in Pharmathen, a Netherlands-based pharma company, from BC Partners, at an enterprise value of nearly €1.6 billion. Funds advised by BC Partners had acquired Pharmathen in 2015 for €475m. Established in 1969, Pharmathen operates as a contract […]